LYKA LABS
Back to Cashflow Statement
|
LYKA LABS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹4.19 Cr | ₹5.29 Cr | ₹1.95 Cr | ₹-22 Cr | ₹-63 Cr |
What is the latest Cash Flow from Financing Activities ratio of LYKA LABS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2026 | ₹4.19 Cr |
| Mar2025 | ₹5.29 Cr |
| Mar2024 | ₹1.95 Cr |
| Mar2023 | ₹-22 Cr |
| Mar2022 | ₹-63 Cr |
How is Cash Flow from Financing Activities of LYKA LABS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2026 | ₹4.19 Cr | -20.90 | |
| Mar2025 | ₹5.29 Cr | 170.97 | |
| Mar2024 | ₹1.95 Cr | Positive | |
| Mar2023 | ₹-22 Cr | Negative | |
| Mar2022 | ₹-63 Cr | - | |
Compare Cash Flow from Financing Activities of peers of LYKA LABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LYKA LABS | ₹302.4 Cr | -5.1% | -1.8% | -10.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹418,204.0 Cr | -1% | -5.5% | 5.7% | Stock Analytics | |
| DIVIS LABORATORIES | ₹238,497.0 Cr | -2.6% | -3.9% | 38.2% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹170,481.0 Cr | -1.7% | -10.2% | 30.5% | Stock Analytics | |
| CIPLA | ₹108,012.0 Cr | 0.9% | -3.2% | -15.2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,207.0 Cr | -0.6% | 1% | -0.1% | Stock Analytics | |
LYKA LABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LYKA LABS | -5.1% |
-1.8% |
-10.5% |
| SENSEX | -1.6% |
-2.3% |
-11.5% |
You may also like the below Video Courses